Interestingly, we observed tumor formation in BCL2L1 KO mouse lungs, suggesting that BCL2L1 plays a crucial role in drug resistance but has no impact on tumorigenesis in EGFR-mutated lung cancer. This evidence concerns the gene BCL2L1 and neoplasm.